The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: AZATHIOPRINE.     Injury: Hepatosplenic T-cell lymphoma     Quarter: 2016Q3

  |<   1/2   << Previous Page   Page 1  

Total Records: 10     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
119878943 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 22.00 YR M 0 20160701 GB
127124421 AZATHIOPRINE. Hepatosplenic T-cell lymphoma MYLAN 0.00 0 20160902 DE
127125211 AZATHIOPRINE. Hepatosplenic T-cell lymphoma MYLAN 0.00 0 20160902 DE
127408491 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 52.00 YR M 0 20160914 US
127408581 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 31.00 YR M 0 20160914 US
127408591 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 35.00 YR M 0 20160914 US
127408651 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 19.00 YR M 0 20160914 US
127408701 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 15.00 YR M 0 20160914 US
127408721 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 12.00 YR M 0 20160914 US
127410371 AZATHIOPRINE. Hepatosplenic T-cell lymphoma RANBAXY 18.00 YR M 0 20160914 US

  |<   1/2   << Previous Page   Page 1  

Total Records: 10     Number of Pages: 1

Execution Time: 0.080664157867432 seconds (ucode:4983272). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.